| Literature DB >> 28587101 |
Inés Mármol1, Cristina Sánchez-de-Diego2, Nerea Jiménez-Moreno3, Carmen Ancín-Azpilicueta4, María Jesús Rodríguez-Yoldi5.
Abstract
Rosa species, rose hips, are widespread wild plants that have been traditionally used as medicinal compounds for the treatment of a wide variety of diseases. The therapeutic potential of these plants is based on its antioxidant effects caused by or associated with its phytochemical composition, which includes ascorbic acid, phenolic compounds and healthy fatty acids among others. Over the last few years, medicinal interest in rose hips has increased as a consequence of recent research that has studied its potential application as a treatment for several diseases including skin disorders, hepatotoxicity, renal disturbances, diarrhoea, inflammatory disorders, arthritis, diabetes, hyperlipidaemia, obesity and cancer. In this review, the role of different species of Rosa in the prevention of treatment of various disorders related to oxidative stress, is examined, focusing on new therapeutic approaches from a molecular point of view.Entities:
Keywords: Rose hip; antimicrobial; antioxidants; arthritis; cancer; diabetes; functional food; neural disorder; oxidative stress
Mesh:
Substances:
Year: 2017 PMID: 28587101 PMCID: PMC5485961 DOI: 10.3390/ijms18061137
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Chemical formulas of hydrosoluble phenolic compounds of rose hips.
Figure 2Chemical formulas of lipid-soluble antioxidants of rose hips.
Figure 3Chemical formula of monogalactosyldiacylglycerol of rose hips.
Anticancer activity of some Rosa species related to their antioxidant activity.
| Rose Species | Cancer Cell Line | Reference |
|---|---|---|
| Cervix epithelioid carcinoma (HeLa) | Tumbas et al. [ | |
| Colon carcinoma (HT-29) | ||
| Non-small cell lung cancer (NCI-H460) | Guimarães et al. [ | |
| Colon carcinoma (HCT-15) | ||
| Hepatocellular carcinoma (HepG2) | ||
| Colon carcinoma (Caco-2) | Jiménez et al. [ |
Bioactive compounds of Rosa spp. and their mechanisms of action in rheumatoid arthritis.
| Activity | Active Compound | Mechanism of Action | References |
|---|---|---|---|
| Anti-inflammatory | GOPO (1,2-di- | Reduction in peripheral blood polymorphonuclear leukocytes, neutrophils and monocytes migration | Larsen et al. [ |
| Fatty acids (triterpenoic acids, ursolic acid, oleanolic acid and betulinic acid) | Inhibition of COX-1 and COX-2 | Jäger et al. [ | |
| Reduction in pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, (IFN)-γ, IL-12) and chemokines CCL5 (RANTES), IP-10 (CXCL10) production | Yan et al. [ | ||
| Inhibition of NF-κB related inflammatory response | Phytosterols | Attenuation of NF-κB phosphorylation | Whang et al. [ |
| Gallic acid | Reestablishment IκBα and NF-κB association | Choi et al. [ | |
| Astragalin and tormentic acid | Inhibition of IkBα phosphorylation and degradation | An et al. [ | |
| Antioxidant | Antioxidants (vitamin C, vitamin E, carotenoids, polyphenols and antioxidant enzymes) | Reduction of ROS production | Kirkeskov et al. [ |
| Inhibition of NO release from macrophages | Kirkeskov et al. [ | ||
| Protection against cell apoptosis, DNA and mitochondrial H2O2-induced damage and amyloid β peptide-induced oxidative injury | Choi et al. [ | ||
| Aqueous extract | Inhibition of RANKL-induced osteoclastogenesis | Cheng et al. [ |
Antibacterial effect of some Rosa species displayed as mean diameter of inhibition zone.
| Bacteria Strain | Mean Diameter of Inhibition Zone (mm) | Reference | |
|---|---|---|---|
| 9.0 | Frey et al. [ | ||
| 8.1 | |||
| 15.4 | Yi et al. [ | ||
| MRSA | 17 | ||
| 18 | |||
| 8 | |||
| 10 | |||
| MRSA | 9.8 | ||
| 9 | |||
| 9.4 | |||
| MRSA | 7.4 | ||
| 8.2 |
Antibacterial effect of some Rosa species displayed as minimal inhibitory concentration (MIC).
| Bacteria Strain | MIC (mg/mL) | Reference | |
|---|---|---|---|
| 0.1 | Kumarasamy et al. [ | ||
| 1.25 | Olech et al. [ | ||
| 1.25 | |||
| 1.25 | |||
| 0.625 | |||
| 1.25 | |||
| 1.25 | |||
| 1.25 | |||
| 1.25 |
Antibacterial effect of some Rosa species displayed as percentage of growth inhibition.
| Bacteria Strain | % Inhibition | Reference | |
|---|---|---|---|
| 80.49 | Talib et al. [ | ||
| 60.69 | |||
| 100.82 | |||
| 101.09 | |||
| MRSA | 95.75 |
Anti-mycotic effect of some Rosa species displayed as mean diameter of inhibition zone.
| Yeast Strain | Mean Diameter of Inhibition Zone (mm) | Reference | |
|---|---|---|---|
| 25 | Yi et al. [ | ||
| 22.8 | |||
| 10 |
Anti-mycotic effect of some Rosa species displayed as minimal inhibitory concentration (MIC).
| Yeast Strain | MIC (mg/mL) | Reference | |
|---|---|---|---|
| 0.156 | Olech et al. [ | ||
| 0.156 |
Anti-mycotic effect of some Rosa species displayed as percentage of growth inhibition.
| Yeast Strain | % Inhibition | Reference | |
|---|---|---|---|
| 98.87 | Talib et al. [ | ||
| 30.72 |
Main active compounds of Rosa spp. extracts and their application in human diseases.
| Phytochemical | Disease of Application | Mechanism of Action | References |
|---|---|---|---|
| Ascorbic acid | Cancer | Anti-inflammatory | Jiménez et al. [ |
| Aging | Antioxidant and anti-inflammatory effect | Phetcharat et al. [ | |
| Arthritis rheumatoid | Inhibition of NO release from macrophages | Kirkeskov et al. [ | |
| Osteoporosis | Stimulation osteoblast differentiation and matrix synthesis | Devareddy et al. [ | |
| Polysaccharides | Cancer | Induction of cytotoxicity in reduction of cancer metastasis by reducing the levels of matrix metalloprotease-9 (MMP-9) | Guo et al. [ |
| Polysaccharide-peptide complex and other polymers | Retroviral infection | Inhibition of viral retrotranscriptase | Fu et al. [ |
| Myricetin | Alzheimer | Inhibition of amyloid β formation and tau-antagonist activity | Semwal et al. [ |
| Quercetin | Age spots | Inhibition of tyrosinase | Fujii et al. [ |
| Gallic acid | Arthritis Rheumatoid | Reestablishment IκBα and NF-κB association | Choi et al. [ |
| Diabetes | Inhibition of α-amylase and α-glucosidase | Ghadyale et al. [ | |
| Ellagic acid | Cancer | Anti-mutagenic and anti-carcinogenic effect | Festa et al. [ |
| Bacterial infections | Downregulation of polyphosphatase kinase 1 (PPK1) | Sarabhai et al. [ | |
| Tellimagrandin I | Bacterial infections | Inhibition of penicillin binding protein 2′ (PBP2) and enhancement of β-lactam antibiotics effect | Shiota et al. [ |
| 1,25-Dihydroxyvitamin D3 analogues | Acute myeloid leukemia | Induction of differentiation | Zhamanbayeva et al. [ |
| Tannin RM-3 | Atopic dermatitis | Anti-inflammatory activity (reduction of the levels of cyclooxygenase 2 mediators and inducible nitric oxide synthase) | Wang et al. [ |
| Unidentified phenols | Bacterial infections | Membrane permeabilisation, extracellular enzymes inhibition, nutrient and energy deprivation by an hyperacidification of plasma membrane interface that disrupts H+-ATPase | Olech et al. [ |
| Dysbiosis | Specific inhibition of pathogenic bacteria growth | Kamijo et al. [ | |
| Prostate cancer | Anti-histone acetyltransferase activity | Lee et al. [ | |
| Urinary tract infections (UTIs) and pyelonephritis | Urease inhibitor | Hassan et al. [ | |
| Isoflavonoid phytoestrogen | Cancer | Stimulation of growing oestrogen dependent cells | Uifălean et al. [ |
| Flavonoids | Obesity | Reduction of PPARγ expression, and prevention of lipid accumulation | Ninomiya et al. [ |
| Epilepsy | Reduction of lipid peroxidation and anticonvulsive effect | Diniz et al. [ | |
| Triterpenoic acids, ursolic acid, oleanolic acid and betulinic acid | Arthritis Reumatoid | Inhibition of COX-1 and COX-2 | Jäger et al. [ |
| Lycopene and other carotenes | Bacterial infections | Anti- | Horváth et al. [ |
| Hyperlipidaemia | Reduction of reduced plasma and liver triglyceride free fatty acid (FFA) levels. | Ninomiya et al. [ | |
| Polyunsaturated fatty acid ω-3, 6 and 9 | Hyperlipidaemia | Reduction of TG synthesis, reduction of the expression of hepatic very low-density lipoprotein (VLDL)-TG, hepatic lipase and Apo CIII and increase Apo CII and VLDL-receptor | Adkins et al. [ |
| Galactolipids | Arthritis Rheumatoid | Reduction in peripheral blood polymorphonuclear leukocytes, neutrophils and monocytes migration | Larsen et al. [ |
| Unidentified compounds from whole extract | Arthritis rheumatoid | Inhibition of RANKL-induced osteoclastogenesis | Cheng et al. [ |
| Diabetes | Hypoglycemic effect and induction of β-cell proliferation | Taghizadeh et al. [ | |
| Acute kidney injury | Anti-inflammatory effect | Zhao et al. [ | |
| Peptic ulcer | Antioxidant effect | Nazıroğlu et al. [ | |
| Depression | Antioxidant effect | Nazıroğlu et al. [ | |
| Antiviral | Inhibition of viral invasion capacity | McCutcheon et al. [ | |
| Unidentified components from fruit extract | Hepatic injuries | Reduction of peroxidation of unsaturated fatty acids | Carlo et al. [ |
| Unidentified components from root extract | Atopic dermatitis | Anti-inflammatory (reduction of cyclooxygenase 2 inducible nitric oxide synthase levels) | Park et al. [ |
| Unidentified components from leaf extract | Diarrhoeal | Anti-secretory activity, inhibition of acetylcholine and histamine activity | Carlo et al. [ |
| Unidentified components from rose powder | Wrinkles | Antioxidant effect: scavenging of reactive oxygen species produced by UV-radiation and decrease of matrix metalloprotease proteins levels | Phetcharat et al. [ |